Medtronic Announces FDA Approval Of SenSight Directional Lead System For Treating Movement Disorders
Executive Summary
Medtronic said it will launch the SenSight DBS in the US after winning FDA approval. The total DBS market is expected to exceed $1bn by 2024, according to Meddevicetracker.
You may also be interested in...
Medtronic Bounces Back During Quarter Four Of Financial Year 2021 As Procedure Volumes Normalize
Medtronic reported strong growth for the past quarter, with CEO Geoff Martha emphasizing the medtech giant’s efforts in M&A and R&D.
Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills, New SaMD Cybersecurity Standards
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.
Market Intel: How Augmented, Mixed And Virtual Reality Tech Unveils New Possibilities For Surgeons
Immersive technologies are becoming a reality in the OR. The second part of Medtech Insight’s series on the “Future of Surgery” introduces innovators of VR simulation tech, AR surgery platforms and AR Smart Glasses, and provides insights from world-renowned AR surgeons.